000 | 01655 a2200469 4500 | ||
---|---|---|---|
005 | 20250517204739.0 | ||
264 | 0 | _c20191211 | |
008 | 201912s 0 0 eng d | ||
022 | _a1499-2752 | ||
024 | 7 |
_a10.3899/jrheum.170661 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPrendecki, Maria | |
245 | 0 | 0 |
_aIncreased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _c05 2018 |
||
300 |
_a686-689 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis _xdrug therapy |
650 | 0 | 4 |
_aAntibodies _xblood |
650 | 0 | 4 |
_aAntithyroid Agents _xadverse effects |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Diseases _xcomplications |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aPeroxidase _ximmunology |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aPropylthiouracil _xadverse effects |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aThyroid Diseases _xcomplications |
700 | 1 | _aMartin, Leyre | |
700 | 1 | _aTanna, Anisha | |
700 | 1 | _aAntonelou, Marilina | |
700 | 1 | _aPusey, Charles D | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 45 _gno. 5 _gp. 686-689 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.170661 _zAvailable from publisher's website |
999 |
_c28185084 _d28185084 |